Heartworm Disease in Dogs: Welfare Through Prevention and Treatment

Heartworm disease causes progressive cardiopulmonary damage in dogs — prevention is simple, but treatment of established infection carries significant welfare risks.

Key Facts

• Dirofilaria immitis is transmitted by mosquitoes and causes worms to develop in the heart and pulmonary arteries
• Signs progress from exercise intolerance to severe heart failure over months to years
• Treatment with melarsomine requires strict exercise restriction to prevent fatal pulmonary embolism
• Monthly preventive medication is safe, effective, and eliminates disease risk entirely
• Dogs in endemic areas (southern US, Mediterranean, tropics) face highest welfare risk without prevention

Welfare Considerations

Heartworm disease inflicts progressive welfare suffering as worms cause pulmonary arterial inflammation, reduced cardiac output, and eventually right-sided heart failure. Affected dogs tire easily, cough, and in advanced disease struggle to breathe at rest. The treatment itself carries welfare risks — the dying worms after melarsomine administration can cause potentially fatal pulmonary thromboembolism, requiring weeks of strict cage rest. The welfare imperative is prevention: monthly macrocyclic lactone preventives administered year-round eliminate virtually all heartworm risk at minimal welfare cost. Testing annually confirms prevention is working. The clear preventive option makes heartworm disease in an unprotected dog an avoidable welfare burden.

What You Can Do

• Administer monthly heartworm preventive year-round in any area with mosquito risk
• Test annually for heartworm antigen even in dogs on prevention — compliance gaps can allow infection
• If treatment is required, commit to 8+ weeks of strict exercise restriction to prevent fatal embolism
• Pre-treat with doxycycline and corticosteroids before melarsomine as directed to improve safety
• Microfilaricide treatment after adult worm kill prevents ongoing transmission from your dog